Clinical Trial Update: Vorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating on vorinostat for locally advanced, recurrent, or metastatic adenoid cystic carcinoma with completed status and results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma
• Oral Cavity Adenoid Cystic Carcinoma
• Salivary Gland Adenoid Cystic Carcinoma

Drugs mentioned

• Vorinostat (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2020-08-03